Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part I
Glaucoma is the main cause of irreversible blindness in the world. Carbonic anhydrase inhibitors (CAIS) used both systemically and topically, reduce intraocular pressure effectively. But unlike systemic CAIs, 2 % dorozolamide and 1 % brinzolamide penetrate deeply into the ocular tissues and do not c...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2020-11-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/1315 |